Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
Glenmark Pharmaceuticals receives tentative ANDA approval for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation)
November 26, 2018
November 22, 2018
November 16, 2018
Glenmark Pharmaceuticals Announces New Data Presentations on RyaltrisTM at the ACAAI Annual Scientific Meeting 2018
November 15, 2018
US Media Contact
For media inquiries only, please contact An Phan, Corporate Communications.
For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.